The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
Open accessAbstract
We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens, and whether molecular mimicry between COVID-19 viral proteins and human tissues could be the cause. We applied both human monoclonal anti-SARS-Cov-2 antibodies (spike protein, nucleoprotein) and rabbit polyclonal anti-SARS-Cov-2 antibodies (envelope protein, membrane protein) to 55 different tissue antigens. We found that SARS-CoV-2 antibodies had reactions with 28 out of 55 tissue antigens, representing a diversity of tissue groups that included barrier proteins, gastrointestinal, thyroid and neural tissues, and more. We also did selective epitope mapping using BLAST and showed similarities and homology between spike, nucleoprotein, and many other SARS-CoV-2 proteins with the human tissue antigens mitochondria M2, F-actin and TPO. This extensive immune cross-reactivity between SARS-CoV-2 antibodies and different antigen groups may play a role in the multi-system disease process of COVID-19, influence the severity of the disease, precipitate the onset of autoimmunity in susceptible subgroups, and potentially exacerbate autoimmunity in subjects that have pre-existing autoimmune diseases. Very recently, human monoclonal antibodies were approved for use on patients with COVID-19. The human monoclonal antibodies used in this study are almost identical with these approved antibodies. Thus, our results can establish the potential risk for autoimmunity and multi-system disorders with COVID-19 that may come from cross-reactivity between our own human tissues and this dreaded virus, and thus ensure that the badly-needed vaccines and treatments being developed for it are truly safe to use against this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179 · cited 2×
“This is of great concern since autoantibodies to phospholipids have been found with COVID-19 and can lead to life-threatening complications of coagulopathy (3).”
BackgroundRisk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.021 · Cited by 2,074
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · cited 1×
“org 2 dysregulation in COVID-19 patients with severe respiratory failure (6).”
BackgroundCOVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission
Gu, J., Han, B., & Wang, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.054 · Cited by 1,501
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019) · Viruses · doi:10.3390/v12010014 · Cited by 1,048 · cited 1×
“Coronaviruses have viral characteristics of being extremely neuro-invasive, with the ability to induce direct damage to the central nervous system via T cells and complement activation (51).”
BackgroundMorita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869
COVID-19 update: Covid-19-associated coagulopathy
Becker, R. C. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02134-3 · Cited by 698
Wang, Y., Liu, S., Liu, H., Li, W., Lin, F., Jiang, L., Li, X., Xu, P., Zhang, L., Zhao, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.002 · Cited by 626
Leaky Gut As a Danger Signal for Autoimmune Diseases
Mu, Q., Kirby, J., Reilly, C. M., & Luo, X. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00598 · Cited by 611
Vojdani, A., & Kharrazian, D. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108480 · Cited by 588
Self-citationViruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms
Smatti, M. K., Cyprian, F. S., Nasrallah, G. K., Al Thani, A. A., Almishal, R. O., & Yassine, H. M. (2019) · Viruses · doi:10.3390/v11080762 · Cited by 544
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china
Han, F., Lin, L., Warby, S. C., Faraco, J., Li, J., Dong, S. X., An, P., Zhao, L., Wang, L. H., Li, Q. Y., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22587 · Cited by 512
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Cardiovascular manifestations and treatment considerations in COVID-19
Kang, Y., Chen, T., Mui, D., Ferrari, V., Jagasia, D., Scherrer-Crosbie, M., Chen, Y., & Han, Y. (2020) · Heart · doi:10.1136/heartjnl-2020-317056 · Cited by 411
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
Segal, Y., & Shoenfeld, Y. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.151 · Cited by 395
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
Kanberg, N., Ashton, N. J., Andersson, L.-M., Yilmaz, A., Lindh, M., Nilsson, S., Price, R. W., Blennow, K., Zetterberg, H., & Gisslén, M. (2020) · Neurology · doi:10.1212/wnl.0000000000010111 · Cited by 371
Subacute Thyroiditis After Sars-COV-2 Infection
Brancatella, A., Ricci, D., Viola, N., Sgrò, D., Santini, F., & Latrofa, F. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa276 · Cited by 370
Zonulin, regulation of tight junctions, and autoimmune diseases
Fasano, A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06538.x · Cited by 364
Fukui, H. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000447252 · Cited by 355
Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study
Hernán, M. A., Jick, S. S., Olek, M. J., & Jick, H. (2004) · Neurology · doi:10.1212/01.wnl.0000138433.61870.82 · Cited by 304
Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination
Partinen, M., Kornum, B. R., Plazzi, G., Jennum, P., Julkunen, I., & Vaarala, O. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70075-4 · Cited by 275
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102573 · Cited by 268
Kanduc, D., & Shoenfeld, Y. (2020) · Immunologic Research · doi:10.1007/s12026-020-09152-6 · Cited by 263
Neurologic complications of coronavirus infections
Nath, A. (2020) · Neurology · doi:10.1212/wnl.0000000000009455 · Cited by 251
Pathology of the thyroid in severe acute respiratory syndrome
Wei, L., Sun, S., Xu, C.-H., Zhang, J., Xu, Y., Zhu, H., Peh, S.-C., Korteweg, C., McNutt, M. A., & Gu, J. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.06.011 · Cited by 233
Fully human antibodies from transgenic mouse and phage display platforms
Lonberg, N. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.004 · Cited by 188
Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition
Bogush, M., Heldt, N. A., & Persidsky, Y. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9752-7 · Cited by 165
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
Anand, P., Puranik, A., Aravamudan, M., Venkatakrishnan, A., & Soundararajan, V. (2020) · eLife · doi:10.7554/elife.58603 · Cited by 162
Lyons-Weiler, J. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100051 · Cited by 161
Ma, W.-T., Chang, C. C.-C., Gershwin, M. E., & Lian, Z. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.003 · Cited by 154
Berg, P. A., Lindenborn-Fotinos, J., Klein, R., & Klöppel, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91327-7 · Cited by 144
On the molecular determinants of the SARS-CoV-2 attack
Kanduc, D., & Shoenfeld, Y. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108426 · Cited by 144
Molecular mimicry and autoimmune thyroid disease
Benvenga, S., & Guarneri, F. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9363-2 · Cited by 133
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
Kanduc, D. (2020) · Antibodies · doi:10.3390/antib9030033 · Cited by 115
Nachamkin, I., Shadomy, S. V., Moran, A. P., Cox, N., Fitzgerald, C., Ung, H., Corcoran, A. T., Iskander, J. K., Schonberger, L. B., & Chen, R. T. (2008) · The Journal of Infectious Diseases · doi:10.1086/589624 · Cited by 113
The role of the blood–brain barrier in hypertension
Setiadi, A., Korim, W. S., Elsaafien, K., & Yao, S. T. (2017) · Experimental Physiology · doi:10.1113/ep086434 · Cited by 112
The Blood–Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders
Costea, L., Mészáros, Á., Bauer, H., Bauer, H., Traweger, A., Wilhelm, I., Farkas, A. E., & Krizbai, I. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215472 · Cited by 112
Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019–2020
Liu, K., Pan, M., Xiao, Z., & Xu, X. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323177 · Cited by 108
Laksitorini, M. D., Yathindranath, V., Xiong, W., Hombach-Klonisch, S., & Miller, D. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-56075-w · Cited by 105
Massive peptide sharing between viral and human proteomes
Kanduc, D., Stufano, A., Lucchese, G., & KUSALIK, A. J. (2008) · Peptides · doi:10.1016/j.peptides.2008.05.022 · Cited by 102
Papoutsopoulou, S., Satsangi, J., Campbell, B. J., & Probert, C. S. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15774 · Cited by 102
Viral infections and molecular mimicry in type 1 diabetes
Coppieters, K. T., Wiberg, A., & von Herrath, M. G. (2012) · Apmis · doi:10.1111/apm.12011 · Cited by 101
Adverse Consequences of Rushing a SARS-CoV-2 Vaccine
Trogen, B., Oshinsky, D. M., & Caplan, A. L. (2020) · JAMA · doi:10.1001/jama.2020.8917 · Cited by 92
On the relationship between human papilloma virus vaccine and autoimmune diseases
Pellegrino, P., Carnovale, C., Pozzi, M., Antoniazzi, S., Perrone, V., Salvati, D., Gentili, M., Brusadelli, T., Clementi, E., & Radice, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.054 · Cited by 86
Schreiner, P., Harrer, T., Scheibenbogen, C., Lamer, S., Schlösser, A., Naviaux, R. K., & Prusty, B. K. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000006 · Cited by 80
Yüksel, H., & Türkeli, A. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1367458 · Cited by 78
Peptide cross-reactivity the original sin of vaccines
Kanduc, D. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s341 · Cited by 75
Molecular Mimicry: Its Evolution from Concept to Mechanism as a Cause of Autoimmune Diseases
Oldstone, M. B. A. (2014) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2013.0090 · Cited by 73
Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system
Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M. S., Grailer, J. J., Zetoune, F. S., Andjelkovic, A. V., Fasano, A., & Ward, P. A. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00196.2012 · Cited by 69
Vojdani, A., Vojdani, E., & Cooper, E. L. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01203.x · Cited by 55
Self-citationMao, T. K., Davis, P. A., Odin, J. A., Coppel, R. L., & Gershwin, E. M. (2004) · Hepatology · doi:10.1002/hep.20491 · Cited by 55
Holder, K., & Reddy, P. H. (2020) · The Neuroscientist · doi:10.1177/1073858420960443 · Cited by 55
Long-Term Outcomes in Patients Surviving Acute Respiratory Distress Syndrome
Wilcox, M. E., & Herridge, M. S. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1246285 · Cited by 53
HPV and systemic lupus erythematosus: a mosaic of potential crossreactions
Segal, Y., Dahan, S., Calabrò, M., Kanduc, D., & Shoenfeld, Y. (2017) · Immunologic Research · doi:10.1007/s12026-016-8890-y · Cited by 49
Gut Bacteria—Not for the Faint of Heart
Mandelbaum, N., Gefen, T., & Geva‐Zatorsky, N. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2019.12.011 · Cited by 27
Vojdani, A., & Vojdani, E. (2018) · International Journal of Alzheimer s Disease · doi:10.1155/2018/1672568 · Cited by 16
Self-citationMolecular Mimicry in Autoimmune Neurological Disease after Viral Infection
Roep, B. O. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456936 · Cited by 6
Cited by
COVID-19 and Myocarditis: Review of Clinical Presentations, Pathogenesis and Management
Lovell, J. P., Division of Cardiology, D. O. M., Čiháková, D., Department of Pathology, J. H. U. O. M., W. Harry Feinstone Department of Molecular Microbiology and Immunology, J. H. U. B. S. O. P. H., Gilotra, N. A., & Division of Cardiology, D. O. M. (2022) · Heart International · doi:10.17925/hi.2022.16.1.20 · Cited by 29
Metadata
- Authors
- Vojdani, A., Vojdani, E., & Kharrazian, D.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-01-19
- Volume
- 11
- Pages
- 617089-617089
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3121259291
- Cited by
- 322
- References
- 59
- FWCI
- 20.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.